Heterozygous HTRA1 nonsense or frameshift mutations are pathogenic
- 16 July 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 144 (9), 2616-2624
- https://doi.org/10.1093/brain/awab271
Abstract
Heterozygous missense HTRA1 mutations have been associated with an autosomal dominant cerebral small vessel disease whereas the pathogenicity of heterozygous HTRA1 stop codon variants is unclear. We performed a targeted high throughput sequencing of all known cerebral small vessel disease genes, including HTRA1, in 3,853 unrelated consecutive CSVD patients referred for molecular diagnosis. The frequency of heterozygous HTRA1 mutations leading to a premature stop codon in this patient cohort was compared with their frequency in large control databases. An analysis of HTRA1 messenger RNA was performed in several stop codon carrier patients. Clinical and neuroimaging features were characterized in all probands. Twenty unrelated patients carrying a heterozygous HTRA1 variant leading to a premature stop codon were identified. A highly significant difference was observed when comparing our patient cohort with control databases (gnomAD v3.1.1 (p = 3.12 x 10−17, OR = 21.9), TOPMed freeze 5 (p = 7.6 x 10−18, OR = 27.1) and 1000 Genomes (p = 1.5 x 10−5). Messenger RNA analysis performed in eight patients showed a degradation of the mutated allele strongly suggesting a haploinsufficiency. Clinical and neuroimaging features are similar to those previously reported in heterozygous missense mutation carriers, except for penetrance, which seems lower. Altogether, our findings strongly suggest that heterozygous HTRA1 stop codons are pathogenic through a haploinsufficiency mechanism. Future work will help to estimate their penetrance, an important information for genetic counselingKeywords
Funding Information
- Agence Nationale de la Recherche
- Recherche Hospitalo-Universitaire (16-RHUS-0004)
This publication has 21 references indexed in Scilit:
- CARASIL families from India with 3 novel null mutations in the HTRA1 geneNeurology, 2017
- Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASILNeurology, 2016
- Unusual case of cerebral small vessel disease with a heterozygous nonsense mutation in HTRA1Journal of the Neurological Sciences, 2016
- Nonsense-mediated mRNA decay in humans at a glanceJournal of Cell Science, 2016
- HeterozygousHTRA1mutations are associated with autosomal dominant cerebral small vessel diseaseBrain, 2015
- A frameshift mutation in HTRA1 expands CARASIL syndrome and peripheral small arterial disease to the Chinese populationNeurological Sciences, 2015
- Features of Cerebral Autosomal Recessive Arteriopathy With Subcortical Infarcts and LeukoencephalopathyStroke, 2014
- Two novel HTRA1 mutations in a European CARASIL patientNeurology, 2014
- Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel DiseaseThe New England Journal of Medicine, 2009
- A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundanceTrends in Biochemical Sciences, 1998